Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Certain hormone treatments can improve acne and related conditions in women.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Premature graying of hair is linked to vitamin D and B12 deficiencies, thyroid issues, iron imbalance, stress, and lifestyle habits, and affects quality of life.

Skin health and diseases are closely linked to metabolic processes.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Most women with Polycystic Ovarian Disease have trouble getting pregnant due to hormonal imbalances, but lifestyle changes and certain drugs can help.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Melatonin may help treat PCOS symptoms in rats.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Growth hormone-releasing hormone (GHRH) boosts hair growth and human scalp hair follicles have their own growth hormone system.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.